Showing results (1-10 of 215) with videos related to
Sort By:
Pageof 22
Expert Opinion on Investigational Drugs|June 25, 2009
Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitorLucy Garvey, Alan WinstonHIV Clinical Trials|December 23, 2011
Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapyLucy Garvey, Veena Surendrakumar, Alan WinstonThe Neuroradiology Journal|October 24, 2015
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohortsShivanee Vigneswaran, Jaime H Vera Rojas, Lucy Garvey, et al.The Journal of Antimicrobial Chemotherapy|October 17, 2015
HIV-1 CNS in vitro infectivity models based on clinical CSF samplesBorja Mora-Peris, Alan Winston, Lucy Garvey, et al.HIV Clinical Trials|April 16, 2015
Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controlsJane Ashby, Caroline Foster, Lucy Garvey, et al.AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.Antiviral Therapy|April 14, 2010
The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patientsLucy Garvey, Ngaire Latch, Otto W Erlwein, et al.International Journal of STD & AIDS|July 4, 2008
Does chronic stress lead to increased rates of recurrences of genital herpes--a review of the psychoneuroimmunological evidence?David Goldmeier, Lucy Garvey, Simon BartonThe Journal of Antimicrobial Chemotherapy|October 12, 2011
CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite studyLucy Garvey, Mark Nelson, Ngaire Latch, et al.Current Opinion in Infectious Diseases|December 3, 2019
Interventions to reduce acute hepatitis C virus in HIV-positive MSMTamara Elliott, Graham S Cooke, Lucy GarveyPageof 22